US Patent Issued to SEOUL NATIONAL UNIVERSITY HOSPITAL on Sept. 9 for "Polypeptide derived from CAP1 and pharmaceutical composition comprising same as effective ingredient" (South Korean Inventors)

ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,410,219, issued on Sept. 9, was assigned to SEOUL NATIONAL UNIVERSITY HOSPITAL (Seoul, South Korea).

"Polypeptide derived from CAP1 and pharmaceutical composition comprising same as effective ingredient" was invented by Hyo Soo Kim (Seoul, South Korea), Hyun Duk Jang (Seoul, South Korea) and Sang Eun Lee (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a polypeptide derived from CAP1 and a pharmaceutical composition comprising the same as an effective ingredient and, more particularly, to a peptide including the amino acid sequence of SEQ ID NO: 1, any 0 to 20 amino acid residues added to the N terminu...